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Introduction: We report a rare but severe pacemaker complication of a pacemaker lead perforating the papillary
muscle. This induced severe tricuspid regurgitation and right heart failure. Patients suffering from right heart failure
have an increased operative risk of open-heart surgery and therefore represent a clinical challenge due to the lack
of clear guidelines.
Case presentation: A 70-year-old male patient presented with severe tricuspid regurgitation and a history of
decompensated right heart failure. One pacemaker lead was described as ‘whipping’. Four years earlier he had
received a VVIR pacemaker with a passive lead. This lead failed after three years and a new ventricular lead had
been placed. We performed on-pump beating heart surgery after a multidisciplinary decision process. One lead
was perforating the posterior papillary muscle, severely impairing valve movement. The tricuspid valve was replaced
with a stented bioprosthesis. Epicardial pacemaker wires were placed on the right and left ventricle to enable cardiac
resynchronization therapy in the case of postoperative heart failure. However, the patient recovered quickly without
left ventricular pacing and could be discharged home 12 days after surgery.
Conclusion: This particular case emphasizes the importance of meticulous surgical technique during pacemaker lead
implantation and a tight postoperative follow-up including echocardiography in complicated cases. The management
of patients with an indication for lead removal having developed secondary severe tricuspid valve dysfunction inducing
ventricular impairment represents a clinical challenge and should be approached by a multidisciplinary team.
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The number of pacemaker implantations is still on the
rise with a broad variety of techniques described and
devices available. Complications are not rare and me-
ticulous attention has to be paid to avoid potential risks
and to identify and treat all kinds of adverse events [1].
Special techniques were recently developed to remove
malfunctioning or infected leads by transvenous lead
extraction devices [2]. However, these techniques have
their limitations and may also lead to severe adverse
events requiring urgent surgical intervention. Therefore,
pacemaker specialists performing lead extraction have to* Correspondence: martin.andreas@meduniwien.ac.at
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techniques.
This case reports a pacemaker lead perforating a papil-
lary muscle. Lead-induced valve dysfunction may induce
ventricular failure years after lead implantation. Once
ventricular dysfunction has developed, the risk of surgi-
cal procedures increase both with regard to perioperative
morbidity and mortality and the therapeutic options are
limited. Clear guidelines are lacking in these patients,
which is especially true for patients with right heart
failure. Therefore, we report this case of an effective
surgical approach in a patient with right heart failure to
provide guidance in this complex clinical setting.
Case presentation
A 70-year-old male patient was admitted to the depart-
ment of cardiac surgery for surgical repair of severel. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 2 Intraoperative view of the perforating lead. Blue arrow:
pacemaker lead perforating the papillary muscle.
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sated right heart failure with recurrent hospitalizations.
Four years earlier he had received a VVIR pacemaker with
a passive lead (Refino 58 ER, Oscor; Palm Harbor, FL,
USA) due to atrial fibrillation with atrioventricular con-
duction block. Three years later, another passively fixed
ventricular lead had been placed due to a failure of the ori-
ginal pacemaker lead resulting in increasing impedance.
The chest X-ray at admission revealed a significantly
enlarged heart and pleural effusions due to right heart
failure (Figure 1). The pacemaker leads did not show a
parallel course through the tricuspid valve. Transthoracic
echocardiography confirmed severe tricuspid regurgita-
tion with a moderate impairment of right ventricular
function (Additional file 1: Video S1). The left ven-
tricle and the other heart valves did not show any
pathologic findings. However, one pacemaker lead was
described as ‘whipping’ in the transthoracic echocardi-
ography (Additional file 1: Video S1).
Clinical decision-making was guided by a multidiscip-
linary approach. Options considered were a conservative
approach due to the increased risk of postoperative right
heart failure, lead removal by percutaneous lead extrac-
tion or open surgical lead removal including valve repair
or replacement. Eventually the decision was taken for
an open surgical approach due to the patient’s good
general health condition and the severely dilated tri-
cuspid annulus.
On-pump beating heart surgery was performed. One
lead was perforating the posterior papillary muscle,
severely impairing valve movement (Additional file 1:
Video S1, Figure 2). Although the lead was not perforat-
ing the leaflet itself, it prevented the free margin of the
posterior leaflet to close in systole due to its strong ad-
hesion to the papillary muscle and the ventricular wall.Figure 1 Preoperative chest X-ray. Blue arrow: pleural effusion;
Red arrow: different course of the two leads through the tricuspid
valve.The leaflet itself was not altered. The tip could not
be completely removed, and can still be seen on the
postoperative chest X-ray (Figure 3). The second lead
could be removed without problems. The valve was
reconstructed with a Contour 3D tricuspid annulo-
plasty ring (Medtronic Inc., Minneapolis, MN, USA).
However, the reconstructed valve showed again mod-
erate regurgitation after weaning from the heart-lung
machine and was replaced with a stented bioprosthesis
(Mosaic Ultra Mitral, Medtronic Inc., Minneapolis, MN,
USA). Epicardial leads were placed on the right and left
ventricle. The lead to the right ventricle was connected
to the pulse generator. The lead to the left ventricle was
routed to the pacemaker pocket to allow cardiac resyn-
chronization therapy in the case of postoperative heart
failure. However, the patient could be weaned from
cardiopulmonary bypass without need for mechanicalFigure 3 Postoperative chest X-ray. Blue arrow: residual lead
fragment.
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tion was good and inotropic support could be stopped
after four days. The left ventricular lead has not been
connected due to sufficient left ventricular function and
the absence of heart-failure symptoms. The patient was
discharged home 12 days after surgery in good condition
and was stable thereafter.Discussion and conclusion
This particular case highlights the importance of meticu-
lous surgical technique during pacemaker lead implant-
ation. Perforations of the leaflet and the papillary muscle
may be avoided by the prolapsing technique. A loop of
the lead is formed by positioning the tip in an area of
the right atrium. Thereafter, the loop rather than the tip
of the lead is advanced into the right ventricle [3]. By
that, a puncture of the valve leaflet or the papillary
muscle is avoided and the coronary sinus cannot be
entered by mistake. Furthermore, a tight postoperative
follow-up including echocardiography should be applied
in complicated cases. Impairment of tricuspid function
after right ventricular lead implantation is not uncom-
mon [3]. A recent analysis associated right ventricular
lead implantation with increased tricuspid regurgitation,
higher pulmonary artery pressure and a dilation of the
right ventricle [4]. Further, a significant lead-induced tri-
cuspid regurgitation was associated with a poor prognosis.
A potential alternative in patients developing tricuspid
regurgitation early after pacemaker implantation would be
to replace the right ventricular lead by a left ventricular
lead placed through the coronary sinus and to remove the
right ventricular lead thereafter.
The lead’s whipping movement should be a warning
sign of lead entrapment in the valvular apparatus. Fur-
thermore, the management of patients with an indication
for lead extraction having developed secondary severe
valve dysfunction inducing ventricular impairment and
right-sided heart failure represents a clinical challenge
requiring a multidisciplinary approach. Although an in-
crease in tricuspid regurgitation is not common after lead
extraction, the use of powered sheath-assisted extraction,
which would have been necessary in this case, was associ-
ated with worsening of valve function [5]. We strongly
believe that lead extraction alone would not have pro-
vided significant benefit in this late disease state. Im-
proved valve function after extraction was unlikely due to
severe annular dilation.
Therefore, we highlight the importance of surgical inter-
vention including valve reconstruction or replacement in
severely symptomatic high-grade tricuspid regurgitation
prior to the development of irreversible right heart failure
according to current guidelines in contrast to lead extrac-
tion techniques or heart failure therapy alone [6].Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Additional file
Additional file 1: Video S1. Preoperative echocardiography and
intraoperative view. The echocardiographic loops show the ‘whipping’
movement of the entrapped lead, the high-grade tricuspid regurgitation
and the intraoperative view.
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